TrialHuman vaccines & immunotherapeutics2022

A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency.

Lei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.